Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : The unknown zone -- Ignore unavailable to you. Want to Upgrade?

To: TheStag who wrote (1354)	7/17/2012 10:36:31 AM
From: globalwarmingisascam	Respond to of 2183

Absolutely, as a weather/climate person, I totally understand. No matter how much I study it and attempt to make logical predictions, nature is a beast and will do what it wants to do...market is same. All with a grain of salt. Nonetheless, I appreciate you sharing your view. DSCO got Surfaxin approval by FDA earlier this year. After FDA approval, they raised a good amount of money, and they were added to R2K. Surfaxin is for premies to help prevent/treat respiratory distress syndrome. I think of it like a diet Coke, with its synthetic sugar, while other similar products are animal derived. Some people don't like the "synthetic" aspect of a drug to use in a premie, but I suspect RN's in the neonatal ICU will prefer synthetic. They gotta market it, but that's what raised money is for. A start for some DD, it's all IMO.